Wednesday , November 25 2020

Moderna will charge $ 25-37 for KOVID-19 vaccine, paper chief executive says

PHOTO PHOTO: Coronavirus: On November 16, 2020, the American biotechnology company Moderna announced a vaccine against KOVID-19 that is 94.5% effective. Montreal, November 16, 2020 / Photo on file

FRANKFURT (Reuters) – Moderna will charge governments $ 25 to $ 37 for a dose of its COVID-19 vaccine candidate, depending on the amount ordered, CEO Stefan Bansel told German weekly Welt am Sonntag (WamS).

“Therefore, our vaccine costs about the same as the flu vaccine, which is between $ 10 and $ 50,” he was quoted as saying.

On Monday, an EU official involved in the talks said the European Commission wanted to reach an agreement with Moderna to procure millions of doses of its vaccine candidate for under $ 25 a dose.

“Nothing has been signed yet, but we are close to an agreement with the EU Commission. “We want to deliver to Europe and we are in constructive talks,” Banchel told WamS, adding that it was only a “matter of days” until the agreement was drafted.

Moderna said her experimental vaccine was 94.5% effective in preventing KOVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to publish results that far exceeded expectations for Pfizer and its partner BioNTech.

The EU has been talking to Moderna about its experimental KOVID-19 vaccine since at least July.

Report by Christoph Steitz; Edited by Mark Potter

Source link